New cervical cancer screening guidance to recommend HPV tests over Pap smears
Key Points:
- For the first time, federal guidance is expected to recommend HPV testing over Pap smears for women aged 30 to 65, including an option for self-administered HPV tests, potentially changing cervical cancer screening for millions.
- The U.S. Preventive Services Task Force (USPSTF) voted on this recommendation, which, if finalized, would require most private insurers to cover HPV testing without cost under the Affordable Care Act.
- Experts highlight that HPV tests detect precancerous changes earlier and more accurately than Pap tests, and self-collection options could increase screening accessibility and comfort for women.
- The new guidance aligns more closely with American Cancer Society recommendations, though some differences remain, such as the starting age for screening and testing intervals for self-collected samples.
- The USPSTF also clarified that women over 65 should stop screening only if they have had several negative results in the past decade; otherwise, screening should continue.